M 1 L Z (Lamivudine and Zidovudine 150 mg / 300 mg)

Pill with imprint M 1 L Z is White, Capsule-shape and has been identified as Lamivudine and Zidovudine 150 mg / 300 mg. It is supplied by Mylan Pharmaceuticals Inc.

Lamivudine/zidovudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 1 L Z

Lamivudine and Zidovudine

Imprint: M 1 L Z
Strength: 150 mg / 300 mg
Color: White
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Antiviral combinations
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mylan Pharmaceuticals Inc.
National Drug Code (NDC): 00378-5180 (Discontinued)
Inactive Ingredients: silicon dioxide, magnesium stearate, microcrystalline cellulose, propylene glycol, sodium starch glycolate type A potato, titanium dioxide
Note: Inactive ingredients may vary.